ST-GALLAY; Stephen
Patent Applications and Registrations
Patent applications and USPTO patent grants for ST-GALLAY; Stephen.The latest application filed is for "macrocyclic sulfonylurea derivatives useful as nlrp3 inhibitors".
- ST-GALLAY; Stephen - Nottingham GB
- St-Gallay; Stephen - Leicestershire GB
- St. Gallay; Stephen - Loughborough GB
| Patent | Date |
|---|---|
| Macrocyclic Sulfonylurea Derivatives Useful As Nlrp3 Inhibitors App 20220289766 - COOPER; Matthew ; et al. | 2022-09-15 |
| Sulfonylureas and sulfonylthioureas as NLRP3 inhibitors Grant 11,370,776 - Cooper , et al. June 28, 2 | 2022-06-28 |
| Sulfonylureas And Sulfonylthioureas As Nlrp3 Inhibitors App 20210130359 - COOPER; Matthew ; et al. | 2021-05-06 |
| Sulfonylureas And Sulfonylthioureas As Nlrp3 Inhibitors App 20210130329 - COOPER; Matthew ; et al. | 2021-05-06 |
| Novel Sulfonamide Carboxamide Compounds App 20210122739 - COOPER; Matthew ; et al. | 2021-04-29 |
| Sulfonylureas And Sulfonylthioureas As Nlrp3 Inhibitors App 20210122716 - COOPER; Matthew ; et al. | 2021-04-29 |
| Novel Compounds App 20210002274 - COOPER; Matthew ; et al. | 2021-01-07 |
| Sulfonamide Derivates As Nlrp3 Inhibitors App 20200407340 - COOPER; Matthew ; et al. | 2020-12-31 |
| Novel Sulfonamide Carboxamide Compounds App 20200361895 - COOPER; Matthew ; et al. | 2020-11-19 |
| Novel Compounds App 20200331886 - MILLER; David ; et al. | 2020-10-22 |
| Novel Sulfonamide Carboxamide Compounds App 20200331850 - MILLER; David ; et al. | 2020-10-22 |
| Novel Sulfonamide Carboxamide Compounds App 20200317637 - COOPER; Matthew ; et al. | 2020-10-08 |
| Novel Sulfonamide Carboxamide Compounds App 20200291003 - COOPER; Matthew ; et al. | 2020-09-17 |
| Sulfonylureas And Sulfonylthioureas As Nlrp3 Inhibitors App 20200270227 - COOPER; Matthew ; et al. | 2020-08-27 |
| Novel Sulfonamide Carboxamide Compounds App 20200216389 - MILLER; David ; et al. | 2020-07-09 |
| Compounds and their uses 707 Grant 8,012,979 - Hallam , et al. September 6, 2 | 2011-09-06 |
| Compounds And Their Uses 707 App 20090023746 - Hallam; Matthew ; et al. | 2009-01-22 |
| Kinase inhibitors as therapeutic agents Grant 7,071,199 - Hirst , et al. July 4, 2 | 2006-07-04 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 